1. Eriguchi N, Aoyagi S, Hara M, Fukuda S, Tanaka E, Hashimoto M. Nonfunctioning islet cell carcinoma of the pancreas: an evaluation of seven patients who underwent resection followed by long-term survival. Surg Today. 1999; 29:233–237.
2. Procacci C, Carbognin G, Accordini S, Biasiutti C, Bicego E, Romano L, et al. Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol. 2001; 11:1175–1183.
3. Sheth S, Hruban RK, Fishman EK. Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. AJR Am J Roentgenol. 2002; 179:725–730.
4. Rodallec M, Vilgrain V, Couvelard A, Rufat P, O'Toole D, Barrau V, et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology. 2006; 6:77–85.
5. McAuley G, Delaney H, Colville J, Lyburn L, Worsley D, Govender P, et al. Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol. 2005; 60:1039–1050.
6. d'Assignies G, Couvelard A, Bahrami S, Vullierme MP, Hammel P, Hentic O, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009; 250:407–416.
7. Ichikawa T, Peterson MS, Federle MP, Baron RL, Haradome H, Kawamori Y, et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology. 2000; 216:163–171.
8. Iglesias A, Arias M, Casal M, Páramo C, Fiaño C, Brasa J. Unusual presentation of a pancreatic insulinoma in helical CT and dynamic contrast-enhanced MR imaging: case report. Eur Radiol. 2001; 11:926–930.
9. Itai Y, Ohtomo K, Kokubo T, Yamauchi T, Minami M, Yashiro N, et al. CT of hepatic masses: significance of prolonged and delayed enhancement. AJR Am J Roentgenol. 1986; 146:729–733.
10. Park MS, Kim KH, Lim JS, Lee JH, Kim JH, Kim SY, et al. Unusual cystic neoplasms in the pancreas: radiologic-pathologic correlation. J Comput Assist Tomogr. 2005; 29:610–616.